CCKBR and small cell lung carcinoma: Paving the Way for CCK2R-Targeted Peptide Receptor Radionuclide Therapy with [&lt;sup&gt;177&lt;/sup&gt;Lu]Lu-DOTA-MGS5 in Patients with Small Cell Lung Cancer.